Increased Incidence of Renal Cell Carcinoma with Hypertension-Reference-Cited by-同舟云学术

Increased Incidence of Renal Cell Carcinoma with Hypertension

Published:1977-10 Issue:4 Volume:118 Page:531-532
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Melman Arnold¹,Grim Clarence E.¹,Weinberger Myron H.¹

Affiliation:

1. From the Departments of Urology and Medicine, Indianapolis Veterans Administration Hospital, Indiana University Medical Center, Indianapolis, Indiana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference11 articles.

1. A comprehensive protocol for the diagnosis of secondary forms of hypertension;Grim;J.A.M.A.,1977

2. Use of an angiotensin II antagonist (Saralasin) in the recognition of “angiotensinogenic” hypertension;Streeten;New Engl. J. Med.,1975

3. Renal carcinoma discovered incidentally by arteriography during evaluation for hypertension;Kirchner;J. Urol.,1976

4. Greenberg, D.: United States Bureau of Statistics. Personal communication.

5. Synthesis and release of parathyroid hormone by a renal carcinoma in cell culture;Greenberg;Clin. Sci. Mol. Med.,1973

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-neoplastic Pathology in Tumor Nephrectomy Specimens;Surgical Pathology Clinics;2014-09

2. Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2013-10-23

3. Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis;British Journal of Clinical Pharmacology;2013-08-20

4. Hypernephroma and Hypertension;Acta Medica Scandinavica;2009-04-24

5. Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis;The Lancet Oncology;2008-02